Research area:
Motor neuron disease
Disease:
Intervention:
Phase:
Research area:
Disease:
Amyotrophic lateral sclerosis
Intervention:
Phase:
Intervention
Therapeutics – Small molecules
Funding awarded to
University of Sheffield, University of Oxford
Public registration details (where available)
Planned trial start and expected end date
February 2024 to September 2028